C1438918||Angiopoietin-like protein 4
C0184511||improves
C0021655||insulin resistance
C0015695||liver steatosis
C0026809||high-fat-diet mice
C1438918||Angiopoietin-like protein 4
C1438918||Angiopoietin-like protein 4
C0033684||secreted protein
C1171362||expressed
C0736268||liver
C0001527||adipose tissues
C1955907||adipokine
C1423931||Angiopoietin-like protein 4
C0017337||gene
C0166418||peroxisome proliferator‑activated receptors
C0003367||lipid‑lowering
C1875327||anti‑diabetic drugs
C2603343||studies
C1438918||Angiopoietin-like protein 4
C0206131||adipocyte
C0023796||lipolysis
C2603343||study
C1438918||Angiopoietin-like protein 4
C1158445||regulating lipid
C2612213||glucose metabolism
C0025929||high‑fat‑diet (HFD) C57 mice
C2603343||study
C0025929||mice
C0025929||chow mice
C0001483||adenovirus
C0001483||adenovirus
C0025929||injected HFD mice
C0001483||adenovirus
C1423931||Angiopoietin-like protein 4
C0025929||injected HFD mice
C0025929||mice
C0015695||liver steatosis
C1287372||serum levels of triglyceride
C1837784||total cholesterol
C0236060||free fatty acids
C0151905||alanine aminotransferase
C0151904||aspartate aminotransferase
C1438918||Angiopoietin-like protein 4
C0015695||hepatic steatosis
C0229671||serum
C0600653||indexes
C0151671||reduced glucose tolerance
C0021655||insulin resistance
C1438918||Angiopoietin-like protein 4
C1171362||expression
C0031715||phosphorylation
C1512804||insulin signaling pathway‑associated
C0017337||genes
C1505029||insulin receptor substrate 1
C1449149||protein kinase B
C1527619||janus kinase 2
C1530114||signal transducer and activator of transcription 3
C0013081||downregulated
C0586688||liver samples
C0001483||Adv
C1423931||Angiopoietin-like protein 4
C0184511||improve
C0021655||insulin resistance
C0017337||genes
C0041904||upregulated
C1438918||Angiopoietin-like protein 4
C1158445||lipid
C2612213||glucose metabolism
C0025933||HFD‑induced obese mice
C0087111||treatment
C0020473||hyperlipidemia
C0011847||diabetes
C0524620||metabolic syndrome
C0012634||diseases